Diabeloop shifts into high gear in France and around the globe

Categorie(s) : Industry, Innovation & Society, News

Published : 7 December 2021

Diabeloop obtained French national health insurance approval for its DBLG1 closed-loop automated insulin therapy device (DBLG1) in September. Now the Grenoble start-up and long-time CEA-Leti partner is training hospital staff so that they can offer the DBLG1 to their diabetic patients. Hospitals in the Île-de-France and Auvergne-Rhône-Alpes regions recently set their first patients up with the device,
which will be rolled out gradually throughout France in 2022. And Diabeloop is also expanding internationally.
The company signed a partnership agreement with leading Japanese medical equipment manufacturer Terumo in mid-November. The partners will integrate Terumo’s patch pump into Diabeloop’s system so that the Japanese company can sell it in Europe.

Contact: stephanie.jegu@diabeloop.fr
More information